Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 11:09 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 937–960 of 2,509 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Apoplexy Clear all

Conditions: Stroke
Interventions: Upper limb-based movement priming (UL-priming), Lower limb-based movement priming (LL-priming), Sham priming; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 40 Years to 90 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hemiparesis, Stroke
Interventions: rTMS, BCI Training; Device · Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 70 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Atrial Fibrillation
Interventions: Rivaroxaban (Xarelto, BAY59-7939); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 12,507 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Aphasia
Interventions: Script Training; Behavioral
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 21 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Carotid Stenosis
Interventions: Bilateral carotid Doppler signal acquisition (Vibrant Stroke Detection Technology); Device
Lead sponsor: Vibrant Medical Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Fibrillation, Atrial, Atrial Fibrillation
Interventions: SB424323; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 640 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 9
States / cities: Mobile, Alabama • Troy, Michigan • Akron, Ohio + 6 more

Conditions: Stroke
Interventions: Motor relearning training, Passive stretching, Gamed-based active movement training, Passive movement, Active movement training, Ankle torque and motion measurement; Device
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 30 Years to 85 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 3
States / cities: Baltimore, Maryland • Houston, Texas

Conditions: Aphasia Non Fluent, Stroke, Aphasia
Interventions: Mirror speech entrainment, Traditional speech entrainment: auditory-only, Traditional speech entrainment: auditory-visual; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Tampa, Florida

Conditions: Atrial Fibrillation, Stroke, Bleeding
Interventions: Rivaroxaban, Warfarin; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Stroke
Interventions: Xeomin®; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 79 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Atrial Fibrillation
Interventions: Rivaroxaban (Xarelto, BAY59-7939), VKA (Vitamin K antagonist); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 38,831 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Urinary Retention, Neurogenic Bladder
Interventions: C2P; Device
Lead sponsor: Spinal Singularity; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 8
States / cities: Peoria, Arizona • Surprise, Arizona • Downey, California + 5 more

Conditions: Intracerebral Hemorrhage
Interventions: NXY-059; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 64
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Fort Smith, Arkansas + 61 more

Conditions: Stroke
Interventions: Blood draw, Stroke blood draw; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 99 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Stroke
Interventions: no intervention; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 4,893 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Cerebral Stroke
Interventions: Reaching Task; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 45 Years to 80 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Acute Ischemic Stroke
Interventions: activPAL device; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Stroke, Hand Weakness
Interventions: NoNo, occupational therapy - self directed; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Stroke
Interventions: Breathing Exercise; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 99 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Stroke
Interventions: Personalized brain state-dependent single-pulse TMS; Device
Lead sponsor: Sara Hussain; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Stroke
Interventions: task-practice therapy, Vibration; Behavioral · Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Ischemic Stroke
Interventions: Stool Samples; Other
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 2
States / cities: Charlottesville, Virginia • Fairfax, Virginia

Conditions: Vascular Disease, Vascular Disease Risk
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 21 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stroke
Interventions: Neuromuscular coordination-guided rehabilitative training, Force strengthening-guided rehabilitative training; Other
Lead sponsor: University of Houston; Other
Eligibility: 40 Years to 75 Years
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Upper Limb-based Movement Priming for Lower Limb Neuroplasticity & Motor Recovery in Stroke

A Brain Centered Neuroengineering Approach for Motor Recovery After Stroke: Combined rTMS and BCI Training

Real-world Dosing Patterns of Rivaroxaban in the United States

Modulating Intensity and Dosage of Aphasia Scripts

A First-in-Human Feasibility Study of the Vibrant Stroke Detection Technology During Carotid Endarterectomies

Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke

Facilitating Neuroplastic Changes of Acute Stroke Survivors

Mirror Speech Entrainment: A Novel Technique for Voice Personalized Speech Entrainment for Nonfluent Aphasia

Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation

Xeomin® and Gait Related Mobility After Stroke

Real-world Comparative Effectiveness of Rivaroxaban Versus VKA

Connected Catheter (C2P) Study for Bladder Management

Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Neuronal and Glial Biomarkers in Stroke

STROKE STAT (Stroke Severity-based Triage to Accelerate Treatment)

Facilitating Implicit Learning to Improve Neurorehabilitation in Stroke

RIsE Stroke Mobility Study

Self-Administered Gaming and Exercise at Home (SAGEH)

Development of Upper Limb Motor Scale to Measure Quality of Movement and Body Awareness in Stroke

Real-time Personalized Brain State-dependent TMS After Stroke

Functional Connectivity & Stimulation-enhanced Therapy Post Stroke

A Study of the Relationship of Gut Microbial Composition and Stroke Outcome

Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease

Increasing the Repertoire of Intermuscular Co-ordination Post Stroke Through EMG-Guided Human-Machine Interaction